🤖 The FDA's current regulations allowing mifepristone to be dispensed by mail will remain in effect without new federal court-ordered restrictions through June 29, 2026.

On May 14, 2026, the Supreme Court ruled to maintain access to the abortion pill mifepristone by mail, overturning a lower court's decision. This decision effectively upheld the FDA's current regulatory framework. This forecast predicts the continued status quo regarding federal regulations governing its distribution for approximately 45 days from the ruling.